Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $75.3400 (7.75%) ($68.8300 - $76.6900) on Wed. Nov. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.04% (three month average) | RSI | 40 | Latest Price | $75.3400(7.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.3% a day on average for past five trading days. | Weekly Trend | LGND declines -12.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(44%) IWN(44%) IWO(43%) IWC(41%) SDY(39%) | Factors Impacting LGND price | LGND will decline at least -2.02% in a week (0% probabilities). VXX(-16%) UNG(-10%) UUP(-7%) TBT(-5%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.02% (StdDev 4.04%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $49.09(-34.84%) | Resistance Level | $81.48 | 5 Day Moving Average | $66.59(13.14%) | 10 Day Moving Average | $74.25(1.47%) | 20 Day Moving Average | $81.48(-7.54%) | To recent high | -30% | To recent low | 21.9% | Market Cap | $1.211b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |